scholarly journals Patients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy

2021 ◽  
Author(s):  
P. V. Morinets ◽  
А. S. Navasardyan ◽  
Е. А. Strebkova ◽  
P. Е. Коmarov ◽  
S. I. Popova ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Social Problem ◽  
Underlying Disease ◽  
Regional Center ◽  
Dosage Regimens ◽  
Coronavirus Infection ◽  
Special Risk

New coronavirus infection (COVID-19) – a serious medical and social problem. Despite the achievement of certain successes in the treatment of patients with COVID-19, there is a need to develop special clinical and organizational approaches in patients with CKD who are on renal replacement therapy and are at special risk due to the course of the underlying disease and concomitant pathology. The article presents the experience of the Samara Regional Center of Nephrology and Dialysis of the Samara Regional Clinical Hospital named after V.D. Seredavin during the pandemic, as well as the features of the management of patients with stage 5 chronic kidney disease undergoing renal replacement therapy in the infectious department to provide MP to patients with COVID-19. Patients with CKD require increased attention, treatment of coronavirus infection (both specific and concomitant) should be carried out in full, while observing the regimens and dosage regimens of drugs and their combinations.

scholarly journals Morbidity, mortality, and renal replacement therapy for chronic kidney disease in Mexico between 2016 and 2018

Nefrología ◽  
2021 ◽  
Author(s):  
Luis Alberto Dorantes-Carrillo ◽  
Martha Medina-Escobedo ◽  
Yaseth Aridai Cobá-Canto ◽  
Alberto Alvarez-Baeza ◽  
Nina Méndez Domínguez
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy

scholarly journals Using machine learning models to predict the initiation of renal replacement therapy among chronic kidney disease patients

PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0233976 ◽  
Author(s):  
Erik Dovgan ◽  
Anton Gradišek ◽  
Mitja Luštrek ◽  
Mohy Uddin ◽  
Aldilas Achmad Nursetyo ◽  
...  
Keyword(s):  
Machine Learning ◽  
Chronic Kidney Disease ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Learning Models ◽  
Machine Learning Models

scholarly journals Severe hyperphosphatemia in a patient with chronic kidney disease and multiple myeloma-to strengthen the case toward renal replacement therapy?

2013 ◽  
Vol 1 (2) ◽  
pp. 72-74 ◽  
Author(s):  
Joerg Latus ◽  
Elisabeth Höring ◽  
Matthias Voehringer ◽  
Dieter Ratge ◽  
M. Dominik Alscher ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Multiple Myeloma ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy

scholarly journals SP031SCREENING FABRY DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITHOUT RENAL REPLACEMENT THERAPY: PRELIMINARY RESULTS OF A MULTICENTER STUDY

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii390-iii391
Author(s):  
Yavuz Yenicierioglu ◽  
Hakan Akdam ◽  
Belda Dursin ◽  
Alper Alp ◽  
Funda Saglam Iyiler ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Multicenter Study ◽  
Preliminary Results

Effect of parameters of renal replacement therapy on platelet aggregation activity

2020 ◽  
Author(s):  
Т.В. Марченко ◽  
А.В. Гончарова ◽  
И.Н. Соловьева ◽  
Е.О. Марченко ◽  
А.М. Исаева
Keyword(s):  
Chronic Kidney Disease ◽  
Platelet Aggregation ◽  
Renal Replacement Therapy ◽  
Kidney Disease ◽  
Replacement Therapy ◽  
Normal Range ◽  
Dialysis Therapy ◽  
Before And After ◽  
Aggregation Activity

Цель исследования: оценить влияние параметров заместительной почечной терапии (ЗПТ) на агрегационную активность тромбоцитов у пациентов с хронической болезнью почек (ХБН). Материалы и методы. Было выполнено 25 процедур гемодиализа (ГД) и 10 процедур гемодиафильтрации (ГДФ) 35 больным с ХБП. Изучали динамику агрегационной активности тромбоцитов до и после экстракорпоральных процедур. Результаты. После процедуры ГД агрегация тромбоцитов снижалась, а после процедуры ГДФ нарастала, не выходя за пределы нормальных значений. Параметры процедур ЗПТ на агрегацию тромбоцитов значимого влияния не оказывали. Заключение. Разовая процедура ЗПТ протяженностью не более 4 ч, проводимая с учетом всех современных требований к диализной терапии, не оказывает негативного влияния на функциональную активность тромбоцитов. Процедура ГДФ приводит к непринципиальному росту агрегационной активности тромбоцитов. Aim: to assess the effect of renal replacement therapy (RRT) parameters on platelet aggregation activity in patients with chronic kidney disease (CKD). Materials and methods. For 35 patients with CKD 25 hemodialysis (HD) procedures and 10 hemodiafiltration (HDF) procedures were performed. We studied the dynamics of platelet aggregation activity before and after extracorporeal procedures. Results. After the HD procedure, platelet aggregation decreased, and after the HDF procedure it increased, without going outside the normal range. Parameters of RRT procedures did not have a significant effect on platelet aggregation. Conclusion. A single RRT procedure not more than 4 hours with all nowadays requirements for dialysis therapy does not adversely affect the functional platelets activity. The HDF procedure leads to an unprincipled increasing of platelet aggregation activity.

Sign in / Sign up

Export Citation Format

Share Document